Published in Front Neurol on March 24, 2015
Is the Motor System Necessary for Processing Action and Abstract Emotion Words? Evidence from Focal Brain Lesions. Front Psychol (2015) 0.77
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations. Front Neurol (2016) 0.75
Correlation Between Daam2 Expression Changes and Demyelination in Guillain-Barre Syndrome. Cell Mol Neurobiol (2015) 0.75
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Thrombosis of the cerebral veins and sinuses. N Engl J Med (2005) 9.47
Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke (2004) 8.77
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30
Cerebral venous thrombosis: an update. Lancet Neurol (2007) 5.17
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Acute disseminated encephalomyelitis: an update. Arch Neurol (2005) 2.45
Hemoconcentration and hemostasis during acute stress: interacting and independent effects. Ann Behav Med (2011) 2.17
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun (2012) 1.82
Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.54
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder. J Neurol (2013) 1.48
Ischaemic stroke: a thrombo-inflammatory disease? J Physiol (2011) 1.46
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) (2005) 1.35
Innate immunity and coagulation. J Thromb Haemost (2011) 1.24
Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findings. J Neurol (2002) 1.21
Thrombosis associated with acute cytomegalovirus infection: a meta-analysis. Eur J Intern Med (2010) 1.16
Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child (2005) 1.14
Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol (2003) 1.07
Venous thrombosis in multiple sclerosis patients after high-dose intravenous methylprednisolone: the preventive effect of enoxaparin. Thrombosis (2011) 1.05
The natural history of relapses in multiple sclerosis. J Neurol Sci (2007) 1.05
Immune mechanisms of stroke. Curr Opin Neurol (2012) 0.97
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun (2014) 0.97
A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol (1998) 0.95
Antiphospholipid antibodies: paradigm in transition. J Neuroinflammation (2009) 0.94
The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology (2005) 0.94
Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler (1999) 0.94
Cerebral venous thrombosis and demyelinating diseases: report of a case in a clinically isolated syndrome suggestive of multiple sclerosis onset and review of the literature. Mult Scler (2005) 0.92
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scler (2012) 0.91
Viruses and multiple sclerosis. Neuroscientist (2011) 0.90
A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci (2010) 0.90
Role of the kallikrein-kinin system in traumatic brain injury. Front Cell Neurosci (2014) 0.86
Helicobacter pylori infection in Neuromyelitis Optica and Multiple Sclerosis. Neuroimmunomodulation (2012) 0.85
Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study. Neuroepidemiology (2012) 0.85
Coagulation in inflammatory diseases of the central nervous system. Semin Thromb Hemost (2013) 0.84
Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol (2007) 0.84
Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders. J Neurol (2014) 0.83
Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation. Ann Neurol (2015) 0.83
Multiple sclerosis etiology: beyond genes and environment. Expert Rev Clin Immunol (2010) 0.83
Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroimmunol (2007) 0.82
High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes. Neurol Sci (2014) 0.82
Cerebral venous thrombosis after lumbar puncture and intravenous high dose corticosteroids: a case report of a childhood multiple sclerosis. Brain Dev (2012) 0.82
Vasogenic edema characterizes pediatric acute disseminated encephalomyelitis. Neuroradiology (2014) 0.81
Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry (2014) 0.79
The syndrome of latent cerebral venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke (1973) 0.79
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study. Neurol Res (2012) 0.77
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. Front Neurol (2014) 0.76
Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis. Eur Neurol (2014) 0.76